NCT02429947

Brief Summary

The purpose of this study is to identify the issues that have greatest impact on QOL for patients with Charcot Marie Tooth (CMT) Disease. Patients who have -registered in the Inherited Neuropathies Consortium Contact Registry will be invited to participate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
411

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

April 20, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 29, 2015

Completed
Last Updated

June 14, 2017

Status Verified

June 1, 2017

Enrollment Period

11 months

First QC Date

April 20, 2015

Last Update Submit

June 9, 2017

Conditions

Keywords

Charcot Marie Tooth diseaseCMTHMSNHMNHSN

Outcome Measures

Primary Outcomes (1)

  • Percentage of participants affected by specific symptoms of CMT.

    The percentage of subjects within the sample who have reported experience with the symptom will be calculated.

    1 year

Secondary Outcomes (1)

  • Severity of impact of each identified symptom of CMT

    1 year

Study Arms (1)

INC Contact Registry Participants

Adult CMT patients who have self-registered at the Inherited Neuropathies Consortium (INC) Contact Registry, a web-based contact registry developed and supported by the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Consortium (RDCRN), located at the University of South Florida.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with CMT, 18 years or older, who have joined the Inherited Neuropathies Consortium RDCRN Contact Registry.

You may qualify if:

  • Patients with CMT that are 18 years or older and have joined the INC RDCRN Contact Registry.

You may not qualify if:

  • Does not have CMT.
  • Does not read or speak English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RDCRN Data Management and Coordinating Center , Epidemiology Center; University of South Florida

Tampa, Florida, 33612, United States

Location

MeSH Terms

Conditions

Charcot-Marie-Tooth DiseaseHereditary Sensory and Motor NeuropathyNerve Compression SyndromesTooth DiseasesCongenital AbnormalitiesGenetic Diseases, InbornHeredodegenerative Disorders, Nervous System

Condition Hierarchy (Ancestors)

Nervous System MalformationsNervous System DiseasesNeurodegenerative DiseasesPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesStomatognathic Diseases

Study Officials

  • David Herrmann, MBBCh

    University of Rochester

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2015

First Posted

April 29, 2015

Study Start

July 1, 2012

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

June 14, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations